Table 5 Changes in the levels of ProBNP from baseline to 2 year follow-up -bezafibrate vs placebo-
| Â | Bezafibrate (n = 58) | Placebo (n = 50) |
|---|---|---|
Absolute change | Â | Â |
   Mean ± SD | 120 ± 524 | 58 ± 307 |
   Median (Interquartile range) | 25 (-14–141) | -20 (-102–87) |
P = 0.02 (Kruskal-Wallis test, unadjusted) | ||
Percent change | Â | Â |
   Geometric mean (95% CI) | 34.1 (8.0–66.3) | -4.3 (-21.8–17.0) |
   Median (Interquartile range) | 21.9 (-9.0–111.8) | -15.8 (-33.1–46.6) |
P = 0.3 (ANCOVA, adjusted for age and baseline ProBNP levels) | ||
P = 0.01 (Kruskal-Wallis test, unadjusted) | ||